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Summary 
Interfacial interactions of polyions in solution has generated a lot of 
interest in the field of self-assembly. Formation of polyelectrolyte multilayers 
at the surface or at the interface can be extended to form structured materials 
like films and fibers respectively. The phenomenon of fiber formation from the 
interface of two polyionic solutions has been demonstrated by Yamamoto et 
al. and Leong et al. using water-soluble polymers.  
In this study, we have demonstrated the formation of fibers by 
polyelectrolyte condensation between plasmid DNA and a set of amphiphilic 
peptides. We have designed amphiphilic peptides of alternating Leucine, 
Alanine and Arginine residues. The peptides form polyelectrolyte complexes 
with plasmid DNA due to the positively charged Arginine units. Additionally, 
the hydrophobic nature of Leucine and Alanine is likely to promote 
interactions between the peptide molecules, thus facilitating fiber drawing at 
higher concentrations. We have also demonstrated fiber formation using DNA 
and two functional peptides. 
We have shown that fibers can be drawn with all seven peptides using 
slight variations in concentrations. All fibers were stable in water for up to 7 
days,  but had varied solubility in 0.1M Phosphate buffer saline (PBS) and 
DMEM (with foetal bovine serum) cell culture medium.  
Fiber morphology under Field Emission Scanning Electron Microscopy 
showed distinct surface patterns on fibers with and without virus. By confocal 
microscopy after fluorescence labelling of the different components, it was 
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found that there was largely uniform integration of the three biomolecules in 
the fibers. 
The transduction ability of the virus-encapsulated fibers was shown using 
using CMV-eGFP baculovirus on U251 and U87 cell lines. To promote cell 
attachment to fiber surface, we also included a RGD motif in the peptide 
design. We also showed that the encapsulated virus particles retained at least 
partial activity in the presence of rat serum. 
This result on virus encapsulation is the first ever reported for 
polyelectrolyte fibers and opens new possibilities for sustained virus-based 
gene delivery. We have demonstrated that the virus retains its activity after 
integration in the fiber, and these fibers provide a sustained release of the 
baculovirus upon incubation with the cells over a period of 72 hours. The 
fibers have also been shown to transduce cells in a localized manner after 
inclusion of RGD motif. This region-specific delivery is a unique feature and 
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1. Introduction 
1.1 Self-assembly in biomolecules 
 
Nature has evolved the ability to assemble a variety of molecules into 
functional and structural architectures. Mimicking this self-assembly in 
synthetic systems is a considerable challenge since biological molecules 
possess the ability to interact in a highly specific fashion on extremely small 
scales. The widely studied ‘bottom-up’ approach to build macro and nano 
structures of biological significance from molecular building blocks derives its 
principles from natural self-assembly. Nature frequently uses bottom-up 
strategy in different processes, e.g. to couple proteins into quaternary 
structures [1-4].  
One plausible approach to form self-assembled structures is to use a pair 
of small molecules – one of which encodes biological information and the 
other directs assembly [5]. Alternatively, these two functions can be 
incorporated in modular form within the same molecule. Such systems driven 
by intermolecular forces shall, spontaneously or upon receiving a stimulus, 
assemble into biomimetic architectures with functional and/or structural 
properties. 
There are, however, significant hurdles to realization of this approach. 
Designing of small molecules that have self-assembling properties is a 
relatively easier task than incorporating biological functionalities in them. This 
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fundamental gap in knowledge results in the restriction of use, problems in 
stability and sterility of these self-assembled structures.  
1.1.1 Forces responsible for self-assembly 
 
A lot of concepts used to predict self-assembly are those that govern 
protein folding. There are primarily three categories of intermolecular forces 
responsible for self-assembly within and across molecular species – 
hydrophobic, electrostatic and hydrogen bonding.  
Hydrophobic interactions 
Hydrophobic interaction is perhaps the most common driving force for self-
assembling molecules. Hydrophobic packing results in a lowering of entropy 
and therefore these assemblies are formed spontaneously and are usually 
highly stable. Amphiphilic molecules comprising of both hydrophilic and 
hydrophobic faces have been used in a variety of self-assembled structures. 
Assembly can easily be controlled by slight modifications in the hydrophobic 
region or chemical structure and a variety of structures – micelles, vesicles, 
sheets, bundles – can be formed. 
Electrostatics 
Some assemblies make use of hydrophobic interactions as a driving force 
and an electrostatic interaction to match together the building blocks. 
Manipulation of charge-charge interactions is a powerful tool for controlling 
structural assemblies. One example is the presentation of therapeutics on the 
structural interface in a controlled fashion. Charged surface is generally an 
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advantage in biological systems since it facilitates solubility, localization and 
interaction with cellular membranes. 
Hydrogen bonding 
Hydrogen bonding is sometimes considered a part of electrostatic 
interactions. This bonding is central to natural self-assemblies, the most 
important occurrence being the interaction between purine and pyrimidine 
bases in DNA. Hydrogen bonding is usually difficult to quantify as it depends 
on the chemical constituents and the angle of the atoms involved. 
1.1.2 Peptide-based self-assemblies 
 
Using short peptides for ‘bottom-up’ constructs has a distinct advantage 
over entirely synthetic oligomers. It allows us to make use of naturally evolved 
structural motifs and even include biofunctional units for greater utility [8].  
Amphiphilic peptides are typically designed with alternating hydrophobic 
and hydrophilic blocks. Alanine and Leucine repeats are commonly used for 
the hydrophobic patches, and Lysine or Arginine serve as the hydrophilic 
parts. By controlling the arrangement of these blocks in the sequence and 
also the surfactant number, various architectures can be achieved [13]. 
Micelles and vesicles 
Micellar structures are common in biological systems in the form of 
phospholipids of the cell membrane. By arranging the hydrophilic residues 
into a short head and a longer hydrophobic tail, amphipathic peptides can be 
made to form micelles and vesicles. Zhang et al. have designed a set of 
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surfactant-like peptides that self-assemble in aqueous solutions into 
supramolecular structures [41-43]. Examples of such amphipathic peptides 
are V6D. Other similar amphiphiles have been reported by Tirrel et al. and 
Stupp et al [12].  
Nanofilaments and nanoropes 
The design of nanofibers and fibrils is borrowed from the natural 
arrangement of β-sheet conformations of fibrous peptides and proteins. By 
placing alternating residues of hydrophobic and hydrophilic amino acids, β-
sheet peptides have been shown to form nanoropes. Examples of such 
peptides are PKFKFFEFEP, AKFKFFEFEA etc. In such assemblies, the 
terminal residues have the important role of controlling fiber growth. In the 
above two sequences, for example, Proline effectively segregates fibers while 
the peptides with Alanine terminal result in random aggregation [14,15].  
Hydrogels and Scaffolds 
Introducing monovalent cations to amphiphilic peptide solutions leads to 
spontaneous assembly into matrices. It is generally easier to form hydrogels 
and matrices with triblock peptides where associating domains at the ends of 
monomeric units act as crosslinkers that result in network formation. 
Hydrogels are a matter of great interest owing to their biocompatibility and 
ability to respond to a variety of physical and chemical cues. Hydrogels can 
find application in drug and gene delivery and providing a microenvironment 
for tissue growth. Gels and scaffolds both have the advantage of providing a 
3D environment for cell culture, which is a more realistic simulation of the 
  6 
physiological environment of the cells. Cell attachment and proliferation can 
be further enhanced by inclusion of motifs like RGD [18-20]. 
1.1.3 DNA-based self-assemblies 
 
DNA molecule can be an important building block for self-assembled 
structures. Its charged phosphate backbone and a helical structure with 
regular grooves can be used to direct specific assemblies via groove-biding 
and intercalation. The high phosphate content in DNA can, via the high affinity 
of phosphate ions for calcium, be used for calcium deposition in bone 
regeneration applications.  Additionally, the presence and knowledge of 
various DNA-binding moieties in nature can be utilized to good effect to 
mediate DNA assembly. DNA recognition linkers have been successfully 
used to construct supramolecular gold nanocrystal structures. Pairs of 
complementary DNA sequences covalently connected to gold nanocrystals 
can recognize each other to build pre-programmed supramolecular 
structures.  
One of the most widely used techniques in DNA self-assemblies is Layer-
by-layer (LBL) process. Layer-by-layer assembly is a process making use of 
oppositely charged polyelectrolytes deposited on a substrate in self-
assembled monolayers. The subsequent layers are alternating between 
positive and negative charges, thus making a ‘sandwich’ of 
polyions.Researchers have demonstrated the formation of multilayered 
functional DNA coatings on quartz, titanium, gold and other substrates via 
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layer-by-layer assembly. DNA assemblies on biocompatible substrates have 
the potential to be used as gene-eluting stents in a timely manner [22,23]. 
DNA scaffolds have also been constructed to organize linear and 
branched assemblies of nanoparticles [24]. These structures find useful 
application in nanoelectronics and biomolecular nanolithography. Single 
stranded oligonucleotide sequences constitute another wide field of research 
by forming various motifs, primarily through intermolecular hydrogen bonding. 
These linear DNA molecules have led to the idea of DNA nanomachines that 
make use of nanowires and molecular switches made of DNA. 
1.1.4 Virus-based self-assemblies 
 
Viruses can be employed as versatile directors of self-assembly due to the 
specific markers present on their surface, which can be manipulated 
genetically and chemically to suit bottom-up building. The high degree of 
organization found in structures formed by viruses and virus-based particles 
is very useful in fabrication of nanoropes and nanowires. M13 bacteriophage 
virus has been of particular interest in such studies due to its generality and 
filamentous structure [24, 25].  
The ability to store genetic information inside the virus genome, which can 
also include composition and crystallographic detail, has proven useful in 
organizing structures on a nanometer scale. By using phage display 
techniques, further information about material-specific peptides can be gained 
and these sequences can then be used for controlling nanoparticle 
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nucleation. Since these peptide sequences are directly linked to the gene 
products, exact and multiple copies can be produced by incorporating the 
specific genetic information in the virus genome. These genetically 
engineered viruses have been shown to form crystalline nanowires and 
conducting films with various nanomaterials. Further examples of these virus-
based self-assemblies are genetically modified cowpea chlorotic mottle virus 
(CCMV) and ferritin, where the inner cavity of virus protein cage was filled 
with metallic ions. Tobacco mosaic virus has also been templated and surface 
modified to make wire-like and tube-like assemblies with semiconductors.  
The unique monodisperse properties of virus particles allow their use in 
the form of virus liquid crystals. A lot of groups have characterized viral 
suspensions for TMV and M13 viruses. The advantage of using viruses for 
such crystal structures lies in the fact that they greatly simplify the complexity 
of a liquid crystal system [26-28].  
Most of these techniques make use of electrospinning or wet spinning 
methods and are inspired by natural processes like the web spinning by silk 
spider. In a specific example, rod-shaped viruses have been demonstrated to 
form 1D fiber structures by extruding the liquid crystalline suspensions 
through micrometer diameter capillaries into cross-linking solutions. The M13 
virus has been shown to form fibrous structures using electrospinning from 
suspensions in organic solvents [28-30].  
These methods usually have the drawback of compromising the virus 
functionality severely. As long as the use of fabricated material does not 
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require active participation of virus, these techniques hold good. But for 
biological applications where it is desirable to retain virus activity, many of 
these methods are unusable. Therefore, there still is immense scope for 
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1.2 Interfacial assembly of biomolecules 
 
Interface assembly is a special kind of self-assembly phenomenon that 
forms the basis for this study. The phenomenon of interfacial polyelectrolyte 
complexation makes use of the fundamental property of polyelectrolytes to 
interact via charge neutralization. Multilayers formed by sequential layering of 
oppositely charged polyelectrolytes have been widely studied for their 
application in drug delivery vectors and coatings. These complexes can be 
used at micro and nanoscale to form structured materials like polyionic films 
and fibers. Interface film formation has received a lot of attention in the past. 
For example, stimuli-responsive peptide films formed by surfactant-like 
molecules have been studied extensively for their foaming and emulsifying 
properties [7]. Interfacial fibers formed via interface assembly have been not 
been researched so extensively. However, previous works by Yamamoto et 
al. on fiber formation between synthetic polymers [32], and by Leong et al. on 
chitosan and alginate fibers [38] have shed some light on interfacial 
interactions of such systems.  
The advantage of such fibers lies in the fabrication process. Aqueous-
based conditions in which the fibers are produced allow the inclusion of 
various biomolecules in the structure. Additionally, these fibers are drawn at 
room temperature and do not need denaturing solvents as required for 
conventional fiber fabrication methods, thus making them an attractive 
material to form scaffolds for tissue engineering and other biological uses. 
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1.2.1 Characteristics of polyelectrolyte fibers 
 
The fibers are drawn by placing droplets of two oppositely charged 
solutions of polyions in close proximity, and then bringing them in contact 
using a needle or sharp tweezers. Fiber can be drawn from the interface of 
the two solutions until one of the polyelectrolyte phases is depleted. This 
process is driven by formation of a polyelectrolyte complex due to charge 
neutralization at the interface, as opposed to interfacial polycondensation 




Figure 2.1 - Process of drawing fibers from a polyelectrolyte interface. The fiber is 
drawn in a continuous upward motion using the help of a mechanical roller. 
 
Image reproduced from Mechanism of Fiber Formation by Interfacial Polyelectrolyte 
Complexation, Macromolecules 2004, 37, 7019-7025. Courtesy Dr.A.Wan. 
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After the fiber formation has initiated, the free end of the fiber can be 
engaged to a mechanical roller to produce sustained fiber drawing. 
Alternatively, a number of small fibers can be drawn by just a pair of tweezers 
by using small volumes of solutions each time.  
An important feature of such fibers is their unusual morphology. The 
‘primary fiber’ is comprised of a number of finer ‘secondary fibers’ of 
submicron diameters that can be seen under the microscope. The primary 
fiber is also marked by beads spaced out at regular intervals. These beads 
can be spread out on glass slides when wet, to observe clearly the secondary 
fibers that give a venation pattern in two dimensions. Upon drying, these 
beads take the form of protuberances on the fiber surface. This phenomenon 
of bead formation gives important evidence for the mechanism involved in 
producing such fibers. 
1.2.2 Factors affecting fiber formation 
 
Viscosity of solutions 
The formation of fibers depends on existence of a stable interface 
between the two droplets of oppositely charged polyelectrolytes. This viscous 
barrier is essential to prevent free mixing of the electrolytes and ensure that 
the complexation remains an interface phenomenon. For most of the 
polyelectrolyte systems, the most stable interface exists only in a narrow 
concentration range.  
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Interfacial area 
The interfacial area between the droplets is important since it determines 
the area of contact where complexation will take place which in turn, 
determines fiber thickness. It also determines to some extent the length of 
fibers formed. To produce continuous fibers of longer lengths, polyelectrolyte 
droplets in channeled plates are more effective than spherical droplets on a 
flat surface.  
Charge density of polyelectrolytes 
A requisite charge density is essential to form polyelectrolyte fibers. 
Oppositely charged polyionic molecules with low charge densities are unable 
to form a distinct interface and eventually result in complex aggregates. In 
some cases, low concentration solutions can form fibers but these are 
unstable and the fibers terminate within very short lengths. 
Draw rate 
The rate of drawing the fiber upwards from the interface has an impact on 
the fiber morphology. At low draw rates, the fiber is beadless while at high 
draw rates, occurrence of beads is a common phenomenon. After labeling the 
constituent polyelectrolytes with quantum dots or fluorescent markers like 
fluorescein isothiocyanate (FITC), the beads show a much higher density of 
polyelectrolyte complex in fibers than the surrounding matrix in wet state. If 
the rate of drawing exceeds the rate of interface mixing and complexation, 
fibers can break off from the interface. 
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1.2.3 Mechanism of fiber formation 
 
Wan et al. have proposed a mechanism for the formation of polyelectrolyte 
fibers [37]. According to the mechanism, the process is constituted of two 
distinct phenomena: an initial nuclear fiber formation and a second 
coalescence step.  To understand these two phenomena, we can divide the 
entire fiber formation process into 4 steps. 
I. Formation of viscous barrier 
Since the free mixing of polyelectrolytes will result in precipitation, the 
formation of a viscous barrier at the interface is the essential first step. This 
film-like barrier limits exchange of polyelectrolytes and ensures that the 
complexation remains restricted to the interface. 
II. Nucleation 
Upon drawing the fiber, the interface gets divided into a number of smaller 
complex regions, which are now free to mix with fresh polyelectrolyte 
solutions. Due to the continuous upward movement of fiber, these 
complexation points act as regions for further nucleation. 
III. Formation of nuclear fibers 
The upward drawing motion results in formation of fibers from the 
complexation zones. This complexation process happens very rapidly (less 
than 5 µs) to form individual nuclear fibers. 
IV. Coalescence of nuclear fibers 
These nuclear fibers coalesce during the drawing motion, and the excess 
polyelectrolytes form beads along the fiber axis. This coalescence results in 
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the characteristic morphology of such fibers – a primary fiber composed of a 
number of secondary nuclear fibers bundled together and interspersed with 
beads.  
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1.3 Gene therapy and delivery 
 
Gene therapy has become one of the most intensively researched 
strategies for current clinical research. It is a powerful tool for treatment of 
diseases caused by mutation in a specific gene. This therapy usually involves 
delivery of a wild-type copy of the gene whose mutation has caused a 
disease. In addition, it also finds application in delivery of genes that stimulate 
immune response, induce cell death or produce a therapeutic protein. The 
common aim of these strategies is to achieve a stable or transient transgene 
expression in the target tissue in a regulated manner.  
Gene therapy can be in vivo – which involves direct injection or transport 
via circulation of the therapeutic gene to the resident cells of the target tissue, 
or ex vivo – in which case the gene is transferred to the cells in vitro followed 
by transplantation of the modified cells into the target tissue [44].  
Efficient delivery of genes in vivo is a significant hurdle to the development 
of gene therapy models. The simplest way of delivering a foreign gene is 
through direct injection of naked DNA. This method, however, has limited use 
because of extremely low delivery efficiency. The presence of several 
physical barriers like the plasma membrane, rapid degradation of DNA by 
nucleases and inability to get inside the nuclear pore complex are serious 
hurdles to DNA delivery. Therefore, majority of current research is focused on 
developing safe and efficient vectors for delivery of genes into tissues. 
Various physical methods like electroporation, particle bombardment (gene 
gun) and ultrasonic transfer have been tested, but are rendered unsuitable as 
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versatile vectors due to limited effective range and possible damage to the 
genomic DNA [45].  
For the ex vivo strategy, identification of an ideal surrogate cell population 
is essential. The cells would have to fulfill various criteria including long-term 
survival in vivo, ability to express transgene at high levels and ease of 
availability. The advantage of ex vivo strategy is the possibility of subcloning 
the cells and using vectors of low efficiency. This strategy translates directly 
into cell therapy using fibroblasts, astrocytes and adult and fetal stem cells. 
The in vivo gene delivery strategies make use of vectors to prevent DNA 
degradation and localization of the cargo to the target tissue. Till date, the 
most effective vectors for gene therapy can be classified in two categories: 
viral and non-viral. Both these types of vectors satisfy the basic requirements 
for a good vector: affinity for cells, protection of therapeutic gene from 
degradation and relatively high transduction efficiency. However, both the 
classes have their advantages and disadvantages thus establishing the need 
for better vectors, possibly by a combination of these two classes.  
1.3.1 Viruses as gene delivery vectors 
 
Over the course of evolution viruses have emerged as natural parasites 
with their ability to infect cells with great efficiency and, very often, high 
specificity. Viruses are capable of transfecting their own DNA into the host 
cell, which is expressed to produced new viral particles.  
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The idea of using viruses as vehicles for transferring and expressing 
genes of interest inside human body first evolved in mid-1960’s. The concept 
of rendering the virus ‘harmless’ and then inserting a therapeutic gene was 
lucrative and in 1970’s, this generated considerable controversy on grounds 
of ethics. Nevertheless, the idea remained afloat and got a major boost by 
successes of molecular cloning. In the past 3 decades, the field has seen 
rapid advancement including approval of several clinical trials.  
However, there are still paramount concerns regarding the use of viral 
vectors in human gene therapy. As viruses have evolved as parasites, they all 
elicit a host immune system response to some extent. In addition to potential 
side-effects in patient, this immune response can also degrade the vector 
prematurely, thus reducing its efficiency. Recent clinical trials have received 
mixed response from the scientific community, primarily due to immunological 
related concerns that led to serious post-treatment effects [53]. 
Mentioned below are the major classes of viruses used for gene delivery. 
Herpes simplex virus type 1 (HSV1) is a common pathogen in humans 
and has high infectivity in neurons and glial cells, as well as several other cell 
types, thereby providing a means of targeting gene transfer to neuronal cells 
that are difficult to reach directly. 
Adeno-associated virus (AAV) is a non-pathogenic small virus. AAV-
based vectors can produce high levels of transgene expression after injection 
into the CNS, and this transgene expression is predominantly in neurons. 
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Adenovirus is another well-known gene delivery vector. In recent years, 
genetically modified adenoviruses have been shown to have high level of 
transgene expression and low immune response. However, the high 
antigenicity of the virion and toxicity of the envelope proteins are 
complications yet to be addressed successfully. 
Retroviruses are enveloped RNA viruses which can transfer genes to a 
wide spectrum of dividing cell types, but this also limits their use as gene 
delivery vectors, although they are well suited for on-site delivery to neural 
precursors and tumor cells. 
Lentivirus is a well known member of the retrovirus family. The main 
advantage of lentivirus-based vectors is their ability to integrate into the host 
genome of both dividing and nondividing cells. But low titers and pathogenic 
characteristics of the vector can limit its utility as a gene delivery system.  
Since all of the above vectors naturally target the mammalian cells, 
immune resistance is a serious obstacle to using larger and repeated dose 
administration. When employing infective viruses, risks due to their 
pathogenicities and immunogenicities are relatively high, thus extra 
consideration must be given to the safety issues [53].  
One of the strategies to circumvent these problems is to use viruses from 
non-human origins for human gene delivery. Without pre-existing immunity, 
human bodies could be less alert or resistant to the vectors, and thus the 
gene delivery could be safer while retaining high efficiency. Furthermore, viral 
vectors from other origins may be non-replicative in human body, in which 
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case they are more controllable and have reduced risk in the gene therapy 
applications. 
1.3.2 Baculovirus Mediated Gene Delivery 
 
Baculoviruses (family Baculoviridae) constitute a group of double stranded 
DNA viruses that cause lethal diseases of arthropods. A member of the 
family, Autographa californica nuclear polyhedrosis virus (AcMNPV), has 
been most commonly used in various researches.  
Previous studies have shown that a wide range of cells and tissues are 
susceptible to baculovirus infection and the resulting transgene expression 
levels are relatively high. These observations indicate that recombinant 
baculovirus can be a powerful vector for various types of gene therapies. On 
the other hand, baculoviruses are non-replicative in mammalian cells, making 
the gene delivery more controllable [54].  
Despite these encouraging results, there are certain hindrances to 
effective use of baculovirus vectors such as a poor in vivo performance due to 
the vulnerability of baculovirus in blood and serum factors presented 
conditions [55]. Researchers have tried to address these issues by using 
different approaches. A prominent strategy is the encapsulation of viruses 
which can provide a longer circulation time and additional protection against 
serum-mediated inactivation. 
Previous attempts to encapsulate viral particles have been focused on 
adenovirus and adeno-associated virus [58]. There have been several 
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approaches tried to envelope viral vectors to prevent serum complement 
inactivation. However, there are only a few reported researches on 
encapsulation of baculovirus, thus leaving a gap to be addressed for better 
applicability of baculovirus vectors [63].  
We have therefore tried to encapsulate baculovirus by integrating it in 
nanofibrous structure inside microfibers produced by non-covalent assembly 
with plasmid DNA and a set of peptides. In addition to providing sustained 
release and, in a specific case, localized expression, these fibers hold the 
potential for offering at least partial protection to the virus in the presence of 
serum. Our attempts focus on devising strategies for improved gene delivery 
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1.4 Use of nano and microfibers in biology 
 
Fibrous materials have always been an integral part of structural 
engineering due to their versatility. With the advancement of tissue 
engineering and biomaterial science, the need for biocompatible fibrous 
materials has grown exponentially. 
Almost all known fibrous structures for use in biology are made of 
polymers. These fibers, with diameters mostly in nanometer range, have the 
advantage of a larger surface area as compared to microfibers. These 
surfaces can be modified and functionalized to suit the specific biological 
purpose. There has been an exponential growth in research on polymer 
nanofibers in the recent years [11]. 
There can be two approaches to inclusion of biologics in fibrous materials 
– by encapsulating the biological molecules inside fibers made of polymers, 
or by incorporating the biologics in the fiber structure itself during the fiber 
fabrication process. There are many methods for fabrication of fibers via both 
approaches. Some of them include template synthesis, phase separation, 
self-assembly, electrospinning and drawing. Among these methods, 
electrospinning is used predominantly for a variety of materials owing to its 
robustness and the potential for mass production. 
Making tissue-engineering scaffolds out of microfibers requires creation of 
an environment that mimics the native extracellular matrix (ECM) in terms of 
both chemical composition and physical structure [19, 20]. Most of the fiber 
formation techniques face a serious challenge in this regard. The chemical 
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and mechanical stress conditions required in fabrication of fibers often proves 
detrimental to proteins and other biomolecules that require milder 
physiological conditions. This has led to elaborate and complicated methods 
for incorporating biological moieties into or on the surface of fibers following 
their fabrication [21].  
These micro and nanofibers find diverse applications in human biological 
therapy. For example, block copolymer fibers produced from poly (L-lactide 
and lactone) via an electrospinning process shows mechanical properties 
comparable to those of human coronary artery. Thus, with surface 
modification, nanofibrous scaffolds made of this material could be used as a 
synthetic extracellular matrix for culturing human smooth muscle cells and 
endothelial cells.  Other polymeric materials like polyurethanes can be used 
to produce biodegradable structures that are highly elastic yet strong, and 
thus useful for soft tissue engineering.  
It must be mentioned that the potential application of polymer nanofibers 
extends far beyond tissue engineering. Due to their high surface area and 
flexibility of design, functionalized nano and microfibers can have broad 
applications as drug and gene delivery carriers [31, 34], biosensors, and 
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1.5 Purpose of the study 
 
Gene therapy holds immense potential for treatment of several lethal 
diseases like cancer. The success of gene therapy relies largely on safe, 
efficient and controllable delivery of a therapeutic gene to the target cell type. 
This can be done using synthetic polymers that have the ability to condense 
naked DNA into nanoparticles and transport it inside cells via charge 
interactions with cell membrane. Lipids and liposomes, proteins and peptide-
linked vectors are other strategies. Together, these gene delivery vehicles fall 
under the category of non-viral vectors. Viral vectors, on the other hand, 
involve genetic modification and engineering of viruses which are natural 
vectors for human cells. Several kinds of viruses have been used for delivery 
of genes to different cell types.  
These two broad and distinct classes of vectors have been extensively 
researched and led to moderate successes and numerous setbacks. The 
non-viral vectors are inhibited by their lack of specificity, low membrane 
permeability and toxicity at higher doses. Viral vectors, on the other hand, are 
highly efficient but suffer from limited DNA carrying capacity and also have 
the risk of immune response which can induce severe side-effects in patients 
and also degrade the vector prematurely.  
It is because of the limited success rate of the two approaches to gene 
delivery that we must look at alternatives, possibly by combining the two 
broad categories of vectors. This new class of ‘hybrid’ vectors should 
combine the positive aspects of both the existing classes and also negate the 
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drawbacks by complementing each other. For example, it has been shown 
previously in our lab that viruses can be coated with non-viral gene carriers 
like polyethyleneimine (PEI) to increase their in vivo circulation time and also 
enhance delivery [unpublished data] .  
We approached the concerns for baculovirus-mediated gene delivery from 
a materials engineering point of view. Baculovirus is an insect virus with no 
known pathology in humans, and therefore is considered safer than other viral 
vectors [54]. We have explored the possibility of controlling baculovirus-
mediated gene delivery in a time and spatially regulated manner using 
principles of self-assembly. Self-assembly is a vast term attracting immense 
amount of research. We have focused on two specific facets of self-
assembling behaviour of molecules in this study. 
The crux of this study is the interactions of a set of amphipathic and 
functional peptides with plasmid DNA and baculovirus. Since all three types of 
biomolecules we focus on are charged and large in size, we have looked at 
the structural assembly of these molecules at microscale. We have utilized 
the phenomenon of interfacial polyelectrolyte complexation to produce 
microfibers made of peptides, DNA and baculovirus.  
There is evidence that virus particles are uniformly incorporated in the 
fiber structure itself as opposed to encapsulation. These fibers, being rich in 
peptide residues, serve the purpose of coating virus particles and mediate a 
slow release when they dissolve in cell culture conditions. Our results show 
that the virus retains almost complete activity after encapsulation. This 
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preliminary evidence holds promise that the peptide residues might prevent 
direct exposure of virus to serum and help a sustained release.  
The second possible application of this structural assembly is in providing 
localized gene delivery. Since the virus is restricted inside a linear fibrous 
structure, it should only transduce cells in the region surrounding it. By 
including a cell attachment motif in the fibers, we have shown that cells can 
adhere to the fibers and show a localized gene expression.  
This study aims to approach the concept of gene delivery via a structural 
route. We have investigated the self-assembling behaviour of three kinds of 
biological molecules: plasmid DNA, baculovirus and a set of short peptides. 
The polyelectrolyte fibers made from these molecules have been 
characterized in detail. We have then shown the advantage of using these 
fibers for delivering the baculovirus to mammalian cells. The two-fold 
advantage – slow release and localized delivery – have been demonstrated in 
vitro.  
This preliminary study is the first of its kind involving three basic 
biomolecules and opens the possibility of further improvement and extensive 
research in such structural assemblies. Furthermore, the versatile nature of 
these biomolecules makes it feasible to functionalize, modify and reengineer 
the basic building blocks of such fibers and may lead to many biomedical 
applications in future. 
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2 Materials and Methods 
 
Below are the materials and methodologies used in the course of this 
research project. Included are the methods for fiber fabrication, 
characterization and cell transduction studies. 
2.1 Materials 
2.1.1 Plasmid DNA and peptides 
 
Plasmid DNA employed was a vector backbone encoding firefly luciferase 
gene (pCAG-Luc, kindly provided by Yoshiharu Matsuura, National Institute of 
Infectious Diseases, Tokyo, Japan). The plasmid was dissolved in Milli-Q 
water to required concentrations and stored at -20° C. 
 
Table 2.1 – List of peptides used in the study. 
 
NAME SEQUENCE NO. OF AMINO 
ACIDS 
   
Tat GRKKRRQRRRPPQC 14 
C-H5-Tat-H5-C CHHHHHGRKKRRQRRRPPQCHHHHHC 26 
AR10 ARARARARAR 10 
AR20 ARARARARAR ARARARARAR 20 
LR10 LRLRLRLRLR 10 
LR16 LRLRLRLRLRLRLRLR 16 
LR10RGD LRLRLRLRLRGRGRDS 16 
   
 
All the peptides were chemically synthesized and purified by GL Biochem, 
China. They were provided in powder form which was resuspended in Milli-Q 
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water (Millipore, Massachusetts, USA) at the required concentrations and 
stored at -20° C. 
2.2 Methods 





Figure 2.1 – Schematic of the fiber drawing process. 
 
 
Aqueous solutions of peptides and plasmid DNA were prepared at a range 
of high concentrations. For drawing one fiber, 5 µL droplets of the positive 
electrolyte and negative electrolyte were deposited on a plastic Petri dish in 
close proximity with each other. The spacing between the droplets was kept 
less than 2 mm. The interface of the droplets was then pulled together using a 
pair of tweezers, and the fiber was drawn in a continuous upward movement 
from the interface. There was some amount of residual solution left after each 







Direction of fiber 
drawing 
  30 
10 µL and even 20 µL droplets of polyelectrolytes, but the volume of residual 
solution increases when using larger volumes. Using 5 µL droplets for each 
fiber ensures minimum wastage of materials. 
 
2.2.2 Characterization of fibers between different peptides 
and DNA 
 
The seven peptides were tested for drawing fibers against plasmid DNA. 
The peptides were divided into three groups as shown below.  
 
Table 2.2 – Grouping of peptides for fiber formation. 
 













  Amphipathic peptides 




For each of the peptides, the concentrations of 5 to 9 µg/µL were tested. 
The concentration range for plasmid DNA was varied from 5 to 9.5 µg/µL in 
intervals of 0.5. Fibers were drawn between plasmid DNA and each of these 
peptides. The concentrations at which the most consistent fibers were formed 
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were noted and optimized. Fibers were air-dried for 5 minutes to a semi-dry 
state and laid on a glass cover slip. The fibers were viewed under a 
transmission microscope at 4X and 10X magnifications. 
2.2.3 Solubility of fibers 
 
The fibers were drawn with plasmid DNA against both LR10 and LR16 
peptides. The fibers were laid in a 24-well plate and topped up with 400 µL of 
solvent that was being tested. The solubility was monitored at different time-
points over a period of one week under room temperature conditions as well 
as cell culture conditions at 37o C and 5% CO2 and observed under 
transmission microscope.  
2.2.4 Preparation and amplification of baculovirus 
 
To generate the recombinant baculovirus used in this study, the transfer 
plasmid pFastBac1 from Invitrogen (Carlsbad, California, USA) was used. 
The human cytomegalovirus immediate-early gene promoter and enhancer 
(cytomegalovirus [CMV] promoter) and eGFP gene from pEGFP-C1 
(Clontech) was inserted between BamHI and EcoRI of pFastBac1.  
Recombinant baculovirus with the above expression cassette was produced 
and propagated in Sf9 insect cells according to the manual of the Bac-to-Bac 
Baculovirus Expression system (Invitrogen). For amplification of the viral 
stock, Sf9 cells were plated in a 75 cm2 cell culture flask (Nunc, Denmark) at 
106 cells per plate. The cells were infected with virus at 0.1 MOI. After 72 
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hours, the cells were collected and centrifuged at 18g for 5 minutes to remove 
any cell debris. The supernatant was collected and concentrated by 
centrifugation at 28,000g for 60 minutes. Viral pellets were resuspended in 
appropriate volumes of 0.1 M phosphate-buffered saline (PBS) and their 
infectious titers (plaque-forming units [pfu]) were determined by plaque assay 
on Sf9 cells. 
2.2.5 Encapsulation of baculovirus in fibers 
 
The concentrated virus at titer of 109 particles per mL was mixed with 
plasmid DNA of concentration 8.5 µg/µL in volume ratio 1:3 followed by 
vortexing for 2 minutes. The resulting solution constituted the negative 
electrolyte for fiber drawing. Fibers were drawn against different peptide 
solutions at concentration 8 µg/µL. 
2.2.6 Fluorescence labeling of biomolecules 
 
Stock solution of Bisbenzimide (Hoechst 33258) fluorescent dye (Sigma 
Chemical Company, Missouri) was prepared by dissolving in Milli-Q water 
(Millipore, Massachusetts, USA) at a concentration of 1 mg/mL and stored in 
dark at 4o C. The labeling solution was prepared by diluting the stock solution 
with water to a final concentration of 5 µg/mL. The labeling solution was 
mixed with 10 µL of 8 µg/µL plasmid DNA by vortexing.  
For PI labeling, Propidium Iodide (Sigma Aldrich, USA) was prepared at a 
concentration of 1 mg/mL. The labeling solution was prepared by diluting the 
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stock to a final concentration of 20 µg/mL. 10 µL DNA was mixed with the dye 
and allowed to react for 2 hours in dark.  
The LR10 peptide was labeled with fluorescein isothiocyanate (FITC). The 1M 
stock solution was diluted to 0.01 M for labeling purpose. The reaction was 
done at dye to peptide molar ratio 1:1.  
Baculovirus particles were labeled with Cy5 mono-reactive dye pack 
(Amersham Biosciences, UK). The virus was resuspended in Sodium 
Carbonate – Sodium Bicarbonate buffer, mixed and incubated with dye for 30 
minutes. The labeled virus was centrifuged at 28,000g for 60 minutes 
followed by thorough washing with 0.1M PBS. The centrifugation and washing 
was repeated to ensure complete removal of unreacted dye. The virus 
particles were resuspended in 0.1M PBS and used for fiber formation. 
For labeling with Hoechst 33258 dye, the virus particles were mixed with 5 
µg/mL dye solution. The solution was then irradiated in a UV crosslinker at 
600 µJ/cm2 for 5 minutes. Since Hoechst is a DNA-binding dye, the irradiation 
was done to expose the virus genome. The labeled virus was then 
centrifuged and washed 2 times with 0.1M PBS and resuspended in 0.1M 
PBS to be used in fiber drawing.  
The labeled biomolecules were used to produce fibers which were laid on 
a glass cover slip and observed under fluorescence microscope at 4X and 
10X magnifications.  
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2.2.7 Confocal microscopy 
 
The labeled fiber was visualized under a confocal microscope (Olympus, 
Fluoview 300, Tokyo, Japan) using a 10X objective lens. The excitation and 
emission for FITC was 510 nm and emission was 530 nm. The excitation and 
emission for PI were 490 and 635 nm respectively.  
The confocal imaging for GFP expression in U251 cells was done using a 
LSM 510 micrscope, (Carl Zeiss, Germany). The fibers were drawn and 
placed on a glass cover-slip inserted in 24-well plates. The cells were allowed 
to incubate on top of the fibers at 37o C for 48 hours to allow for GFP 
expression. After 48 hours, the cell culture medium was removed and the 
cells were washed with 0.1M PBS. The cells were fixed using 3.7% buffered 
paraformaldehyde for 15 minutes at 37o C. The cover-slips were then 
extracted from the well-plate and visualized under confocal microscope  
2.2.8 Field Emission Scanning Electron Microscopy  
 
Field emission scanning electron microscopy (FESEM) was done on a 
JEOL JSM-7400F electron microscope with accelerating voltage at 10KV. 
2.2.9 Surface charge measurements 
 
An electrokinetic analyzer (AntonPaar GmbH, Austria) was used to 
measure the surface zeta potential of the fibers. The fibers were prepared, 
air-dried and inserted in a stamp cell for measurement. 0.1 mM KCl at pH 6.5 
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was used as dilute electrolyte. KCl was circulated through the measuring cell 
containing the fibers at maximum pressure of 300 mbar in both flow 
directions. The zeta potential of the surface was recorded using the potential 
difference between the two charged interfaces in 8 runs for each sample. 
2.2.10 Cell culture and transduction studies 
 
Human glioma cell lines U251 and U87 were grown in DMEM 
supplemented with 10% fetal bovine serum and 1% penicillin and 
streptomycin. All the cell lines were obtained from ATCC (American Type 
Culture Collection, VA, USA). The cells were maintained in a humidified 
incubator with 5% CO2 at 37°C. Transduction studies were performed in 24-
well plates. Fibers were drawn using 10 µL of baculovirus and appropriate 
volume ratios of DNA and peptide for each well. The fibers were laid on the 
bottom of the well carefully and cells were seeded on top of the fiber at 
confluency of 5 X 104 cells per well in 350-400 µL of medium. The cells were 
incubated at 37°C and observed under the microscope for GFP expression 
every 24 hours.  
For testing localized gene delivery from fibers, fibers were drawn and laid 
on a 35 mm round glass cover-slip in a specific pattern and the cover-slip was 
carefully inserted in 24-well plate. The cells were then seeded on top of the 
cover-slip and the cells were incubated at 37°C without disturbing the plate. 
The medium was removed after 48 hours and the cells were washed with 
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0.1M PBS followed by fixing with. The cover-slip was then extracted using 
tweezers and viewed using a confocal microscope. 
For studies using native serum, DMEM with 10% fetal bovine serum and 
1% penicillin and streptomycin was supplemented with 2% rat serum (Sigma). 
Fibers were drawn according to the protocol above and cells were seeded on 
top of the fibers at confluency of 5 X 104 cells per well in 350-400 µL of 
medium. The cells were incubated at 37°C and observed under the 
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CHAPTER III 
RESULTS
  38 
3 Results 
 
3.1 Stability of viscous interface  
 
The fiber-forming ability of polyelectrolytes is dependent on the stability of 
the viscous barrier between the two solutions. A range of concentrations were 
tested for all the peptides. The results are summarized in table 3.1.  
 
 
Table 3.1 – Concentration range for fiber formation between peptides and DNA. 
 
                                    Peptide concentration (µg/µL) 
 5 6 7 8 9 
5 
 
    
5.5      
6      
6.5      
7      
7.5      
8      
8.5      






9.5      
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As seen from the table, the polyelectrolytes form fibers only within a 
specific range of concentrations. Plasmid DNA concentrations less than 7.5 
µg/µL were unsuitable for forming a viscous interface long enough to draw a 
fiber. On the other hand, concentrations higher than 8.5 µg/µL resulted in 
rapid precipitation of polyionic complex in the solution, thus preventing fiber 
drawing. By calculating the molar ratios at the best concentration of 8 µg/µL 
for both the electrolytes, we found that due to the large size of plasmid DNA 
(6000 bp), the ratio of peptide to DNA was 4000:1.  
3.2 Fiber forming ability of peptides 
 
We tested 7 peptides for interfacial fiber formation with plasmid DNA. The 
first group consisted of 2 peptides based on HIV-coded Tat regulatory protein. 
The second group consisted of 4 amphiphilic peptides with alternating 
hydrophobic and positively charged amino acids. Additionally, we tested a 1:1 
ratio of amphiphilic peptide LR10 and LR10 functionalized with RGD motif. 
We found that all the 7 peptides were capable of forming interfacial 
polyelectrolyte fibers with plasmid DNA, though with varying morphology and 
consistency. For all peptides, a general concentration range of 6 – 8 µg/µL 
was found to be optimum for fiber drawing. A slightly higher concentration (9 
µg/µL) was required while using Tat and functional Tat peptides.  
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Figure 3.1 – Morphologies of different fibers. Scale bar is 100 µM in each case. 
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The best and most consistent fibers were drawn with LR10 and LR16 
peptides. So we chose these two peptides for further characterization and 
optimization studies. 
3.3 Solubility of polyelectrolyte fibers 
 
We tested the solubility of LR10 and LR16 fibers in water and PBS buffer 
system. Both types of fibers were insoluble and stable in water even up to a 
period of 7 days. We also tested the effect of DMEM cell culture medium with 
10% fetal bovine serum on fibers. LR16 fibers remained insoluble in the 
medium even up to 7 days, but LR10 fibers degraded and dissolved within 10 
hours (figure 3.2). This difference in solubility between the two fibers is quite 
remarkable and further characterization studies may offer some explanation 




























Figure 3.2 – Solubility  of LR10 and LR16 fibers. 
a) and b) show LR16-DNA fiber in DMEM with fetal bovine serum on top of U87 cells 
at 0 and 24 hours respectively. c) and d) show LR10-DNA fibers under same 
conditions at 0 and 24 hours respectively. 
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3.4 Encapsulation of baculovirus in fibers 
 
Having optimized the concentration and other parameters for fiber 
drawing, we proceeded to test whether these fibers are suitable for 
encapsulation of biologics. We found that by mixing baculovirus particles – 
which have a net negative surface charge at physiological pH – with plasmid 
DNA, it is possible to draw fibers against the LR peptides. The baculovirus 
particles were suspended in 0.1M Phospho-buffer saline (PBS) at a titer of 2 
X 109 pfu per mL. The ratio of DNA to baculovirus was optimized for fiber 
drawing at 3:1 by volume. The fiber had the same diameter as LR10–DNA 
fibers without virus encapsulation, when observed under light microscope. 
Fluorescence microscopy images of baculovirus labeled with Cy5 and 
Hoechst dye confirmed that the virus particles were uniformly incorporated in 




























Figure 3.3 – Fluorescence microscopy of virus encapsulated in fibers. 
a) Cy5 labeled baculovirus and b) Hoechst-labeled baculovirus encapsulated in 
LR10-DNA fiber.  
8 µm 
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3.5 Surface topography of fibers 
 
We used Field Emission Scanning Electron Microscopy (FESEM) to study 
the surface morphology of the fibers. FESEM is a common imaging technique 
used to visualize structures as small as 1 nm. FESEM employs electrons 
generated in a 'source' (Emission) and accelerated under influence of a 
strong electrical voltage gradient (Field). The electron beam then scans the 
specimen and secondary electrons are produced by interaction with the 
atoms at the surface of the sample. These electrons can reconstruct a very 
detailed image of the topography of the surface of the specimen.  
We compared the morphology of the fiber with and without encapsulation 
of baculovirus. There is noticeable difference between the surfaces of the two 
fibers. The fiber without encapsulated virus shows very faint indents along the 
fiber length, and these are likely to form due to the continuous drawing 
movement along the fiber axis during the formation of fibers (figure 3.4a, b). 
The fiber with baculovirus shows much deeper and prominent ridges on the 
surface parallel to the fiber axis, as compared to the smoother surface 
morphology of the fiber without virus (figure 3.4c, d). These ridges are present 
throughout the length of the fiber and are probably due to the incorporation of 
virus particles between the thinner nuclear fibers  
 









Figure 3.4 – FESEM images of LR10-DNA fibers without and with baculovirus 
encalsulation.  
The surface of a single fiber without baculovirus seen at a) 5000 and b) 10,000 
magnification is smooth with faint ridges while the surface of the fiber including virus 
c) and d) is deeply grooved with parallel ridges along the fiber axis. 
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3.6 Fluorescence and confocal studies 
 
In order to study the constitution and inner structure of fiber, the peptides 
and the plasmid DNA were labeled with fluorescence dyes and the fibers 
were viewed under fluorescent and confocal microscopes. The fibers were 
imaged in wet state so as to see the inner nuclear fibers clearly.  
We labeled plasmid DNA with Hoechst 33258 dye, which is a fluorescent dye 
that binds to the minor groove of the DNA. The bound dye is excited by 365 
nm light (long UV) and it fluoresces at 458 nm.  
As is evident from figure 3.5, the plasmid DNA is uniformly incorporated in 
the fiber as one of the two polyelectrolytes. Figure 3.5c shows one end of the 
fiber where the primary fiber has broken and the inner nuclear fibers can be 
seen clearly.  
For confocal imaging, the peptide was labeled with fluorescein 
isothocyanate (FITC) green dye and plasmid DNA was conjugated with 
propidium iodide (PI) at 1:1 molar ratio. The confocal scans are shown in 
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a)  b)  
c)  
Figure 3.5 – Fluorescence microscope images of a LR10-DNA fiber with Hoechst 
labeled DNA. 
a) without  and b) with Hoechst blue labeled DNA at 10X magnification. Images show 
uniform incorporation of DNA in the fibers. Image c) shows one end of the fiber 
where the separate nuclear fibers can clearly be seen. All images were taken with 
the fiber in wet state for better visualization. 
 





















Figure 3.6 – Confocal scans of fiber with fluorescent labeled peptide and DNA 
a) Overlay and b) dark field confocal microscopy images of a LR10-DNA fiber made 
of FITC-labeled peptide and PI-labeled DNA. The images show equal incorporation 
of the two biomolecules in the fiber. Various yellow regions show the presence of 
peptide and DNA complex. 
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The images in figure 3.6 show distinct green and red regions indicating the 
presence of peptide and DNA respectively. In addition, there are continuous 
yellow regions where the DNA and peptide overlap. Since the fiber is 
composed of several layers of nuclear fibers, it is hard to distinguish the exact 
binding of peptide with DNA. But the uniform presence of peptide and DNA as 
constituent electrolytes was further confirmed. 
3.7 Surface charge analysis 
 
An electrokinetic analyzer (AntonPaar GmbH, Austria) was used to 
measure the surface zeta potential of the fibers. This flow-through technique 
is based on the measurement of streaming potential and streaming current. A 
dilute electrolyte (0.1 mM KCl) is circulated through the measuring cell 
containing the solid sample, thus creating a pressure difference. The relative 
movement of the charges in the electrochemical double layer – the surface of 
the fiber and the electrolyte - gives rise to the streaming potential. This 
streaming potential is detected by electrodes placed at both sides of the 
sample.  
The zeta potential for the peptide–DNA fiber was measured to be -14.78 
mV at pH 6.5 and 26o C with standard deviation of 0.181 in 8 measurements. 
The negative charge on the surface of the fiber was found in accordance with 
our expectation, due to the highly negatively charged DNA molecule.  
The surface charge of the fiber after virus encapsulation was -16.8 mV at 
pH 6.5 and 26o C with standard deviation of 0.17 in 8 measurements. We 
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have previously measured the charge on naked baculovirus as -10 mV (±2 
mV) at the same pH and therefore, a slightly more negative value for the fiber 
after inclusion of the virus was as expected. These results suggest that at 
least some fraction of the encapsulated virus is exposed to the surface.  
3.8  Cell transduction studies 
 
Before testing the release of baculovirus from fibers, we tested whether 
the high peptide concentration required to form the fibers could affect 
baculovirus activity. We used Tat peptide for this experiment as it is a well-
known sequence for mediating cellular uptake. As compared to the LR 
peptides, which have no known biological function, Tat peptide would be 
more effective in testing the charge effect on baculovirus. Since it is not 
possible to form fibers at lower concentrations, complexes of Tat peptide and 
baculovirus were prepared at different molar concentrations of ‘N’ – the 
number of positive residues on one peptide – by simple mixing. The molar 
concentrations of ‘N’ were varied from 0.01 µmol to 1 µmol. CMV-eGFP 


































Figure 3.7 – Effect of peptide concentration on virus activity. 
Transduction efficiency fell significantly from a) control b) 0.01 c) 0.1 d) 0.5 and e) 1 
molar N of peptide concentration. 
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As seen in figure 3.7, increasing peptide concentration can significantly 
impede baculovirus activity. The transduction efficiency at the lowest 
concentration (0.01 µmol) was comparable to the positive control. On 
increasing the peptide concentration to 1 µmol, there was almost no infection 
indicating a complete loss of virus activity.  
Since the fiber forming process necessarily employs a high peptide 
concentration, we tried to solve this problem by pH variation. Previous studies 
done by us show that at alkaline pH the virus is positively charged. If the virus 
inactivation is due to the surface coating by peptide molecules, we 
hypothesized that increasing the pH would render this binding weak and 
restore the virus activity.  
We prepared the Tat–baculovirus complexes by simple mixing using 0.5 
µmol ‘N’ from pH 5 to 9. The pH was varied while preparing the electrolyte 
solutions. The cells were incubated with the complexes for 24 hours and then 



































Figure 3.8 – The effect of pH of electrolyte solutions onbaculovirus activity.  
The  positive control a) was free baculovirus at pH 7.4. The images show that at b) 
pH 5 and c) pH 6 have little or no transduction. But the complexes prepared at d) pH 
7 e) pH 8 and f) pH 9 efficiently transduced the cells. The best activity was observed 
at pH 8. 
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Figure 3.8 shows the effect of increasing the pH of the constituent 
electrolytes on virus activity. There was negligible transduction at pH 5 but the 
number of infected cells increased while moving to pH 9. The intensity of 
fluorescence was still not as bright as the positive control but the number of 
green cells infected was comparable. This is most probably the result of 
weakened charge interactions between peptide and virus envelope.  
 
3.8.1 Sustained release of baculovirus from fibers 
 
Having optimized the pH and concentration conditions for encapsulating 
baculovirus, we tested the transduction ability of baculovirus released from 
fibers in U251 and U87 human glioma cell lines. The virus was encapsulated 
in LR10–DNA fibers at pH 8. After 24 hours of incubation with the cells, we 
observed almost no transduced cells. However, the cells began to show 
expression 48 hours after incubation and the efficiency was comparable to 
the control after a 72 hour period (figure 3.9). This result suggests the ability 
of the fiber to shield the virus and provide a sustained release over 72 hours 
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a)   
b)   
c)  
 
Figure 3.9 – Sustained release of baculovirus from LR10-DNA fibers.  
The images show U251 cells transduced with CMV-eGFP baculovirus released from 
fibers. The left panel shows positive control and the right panel shows transduction 
from fibers a) 24 hours b) 48 hours and c) 72 hours after incubation.  
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3.8.2 Cell attachment and localized gene delivery 
 
One hurdle with using these fibers for transduction studies was their 
inability to interact with the cells. In the standardized protocol, the fibers are 
placed at the bottom of the well plate and cells are seeded on top. Due to 
absence of any membrane targeting motif and an overall negative charge, the 
fibers do not attract cells. As a result, most of the fiber regions are avoided by 
cells, creating large blank spaces with no transduced cells after the fiber has 
dissolved. 
To overcome this problem, we modified the peptide design by 
incorporating an RGD motif in LR10 peptide. The RGD motif has been well-
studied and shown in various studies to promote cell attachment. However, 
no fibers were formed with this peptide at the same concentration range. We 
then optimized a 1:1 ratio of LR10 and LR10-RGD peptides at 8 µg/µL each 
for drawing fibers. This ratio produced consistent and strong fibers against the 
DNA and virus suspension. The morphology of the fibers was also similar to 
LR10 fibers.  
We then proceeded to study the effect of RGD motif on cell attachment to 
fibers. Figure 3.10 shows U251 cells attached to the functionalized fiber. The 
attachment of cells on the fibers also leads to the possibility of localized gene 
delivery. If the fibers are arranged in a pattern on a glass cover-slip and then 
cells are seeded on top, it is possible to observe transduction only in the fiber 
region. The confocal scans in figure 3.11 show that these fibers can be used 
for localized gene delivery. 





















Figure 3.10 – Attachment of cells on fibers after incorporation of RGD motif in the 
peptide.  
a) Cells on LR10 fiber without RGD motif do not attach while b) a number of cells 
(marked by red circles) attach on the fiber surface after RGD modification. The 
images were taken 5 hours after seeding the cells. 
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 a)  
b)  
Figure 3.11 – The confocal tile scans of U251 cells with localized gene delivery 
using RGD peptide. 
a) overlay and b) dark-field show U251 cells on LR10RGD-DNA fibers. The position 
of the fiber was marked on the cover slip and the cells were observed 48 hours after 
incubation. The total scan area is 4000 µm X 4000 µm  
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3.8.3 Transduction in the presence of rat serum 
After having studied the release profile of baculovirus from the fibers, we 
tested the possibility of virus protection against serum inactivation. The fibers 
were produced according to the optimized protocol and incubated with U251 
cells in the presence of DMEM cell culture medium with 10% heat inactivated 
FBS and 2% rat serum (Sigma). Free baculovirus under the same conditions 
served as the negative control, while fibers without rat serum served as 
positive control. The cells were incubated with fibers for 48 hours and the 
GFP expression was observed under a fluorescent microscope.  
As seen from figure 3.12, the concentration of serum used only partially 
inactivated the free baculovirus. The expression in the wells containing fibers 
is comparable to the positive control. Additionally, the fibers show similar 
release profile as in serum-free medium.  









Figure 3.12 – Transduction of U251 cells in the presence of 2% rat serum.  
a) Unprotected virus in serum-containing medium b) Fibers in serum-containing 
medium c) fibers in serum-free medium. The images were taken 48 hours post-
incubation. 
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4 Discussion 
4.1 Formation of Polyelectrolyte fibers 
 
Amphiphilic peptides have been demonstrated as versatile building blocks 
for self-assembled structures. There has been extensive research on the 
spontaneous interaction and assembly of these peptides amongst 
themselves. On the other hand, interfacial interactions of polyelectrolyte 
solutions is also a well-studied field and polyelectrolyte fibers are another 
example of driven self-assembly.  
In this work, the two approaches towards self-assembly – using di-block 
amphiphilic peptides and the phenomenon of interfacial complexation – have 
been combined to form functional microfibers incorporating baculovirus. This 
is the first known attempt to produce such fibers using DNA. It is also the first 
instance where a viral particle has been successfully incorporated in the fiber 
structure, although some previous work has shown viral fibers made by 
alternate methods.  
4.2 Design of the peptide sequences 
 
We designed three groups of peptides for interaction with plasmid DNA as 
given in Table 2.2. The first group consisted of the Tat peptide sequences 
derived from arginine-rich basic domain of the HIV transactivator of 
transcription. The Tat peptide belongs to the class of short peptides called cell 
penetrating peptides (CPPs) and has been studied intensively during the last 
decades for its ability to translocate across the plasma membrane. This 
property can prove beneficial for gene delivery purpose. We used the primary 
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sequence of Tat, given by GRKKRRQRRRPPQC, as well as a second 
modified Tat sequence, given by C-H(5)-Tat-H(5)-C. Both these sequences 
have been well researched and documented by our lab for improved DNA 
delivery efficiency. The hypothesis was that the predominant positive charge 
of the peptides might allow for interfacial charge interactions with the 
phosphate backbone of DNA.  
The second group of peptides was designed based on the amphipathic 
sequences classified by Zhang et al. and Stuup et al [12, 42-44]. These 
peptides are efficient drivers of spontaneous self-assembly within themselves 
and form a variety of nano and micro structures. Most of the previous work 
has focused on studying the hydrophobic interactions of these peptides, 
although the charged residues have been employed for micelle formation in 
some studies. And while the peptide-peptide interactions have been 
extensively studied, the interaction of these versatile peptides with other 
biomolecules has received relatively less attention. We hypothesized that 
these peptides could interact with negatively charged DNA molecule and 
these interactions, combined with inter-peptide interactions, could lead to a 
structural assembly.  
We chose Arginine as the positive amino acid in all our sequences. With a 
pKa of 12.48, arginine is positively charged in neutral, acidic and even most 
basic environments, and also has the ability to form multiple H-bonds. For the 
hydrophobic residues, we used Leucine and Alanine units. Using LR and AR 
repeats, the peptides LR10, LR16, AR10 and AR20 were designed.  
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We designed a third type of peptide with an RGD motif to improve the 
biological functionality of the polyelectrolyte fibers. The RGD sequence – 
originally identified as the sequence within fibronectin that mediates cell 
adhesion – is simply a tripeptide motif of Arginine, Glycine and Aspartic acid 
residues. It is found in many proteins and has been proved often to support 
cell attachment. We designed our peptide sequence with a GRGRDS motif 
attached to the C terminus of peptide LR10. The hypothesis was that this 
sequence can enhance cell attachment to the fiber surface and thus facilitate 
interaction between fiber components and cells.  
In the second part of the work, we attempted to encapsulate baculovirus 
particles inside the polyelectrolyte fibers. Previous work done by Wan et.al. 
has shown that different biologics can be encapsulated in such fibers. 
However, our work is the first demonstrated evidence for encapsulation of a 
virus inside polyelectrolyte fibers.  
4.3 Characterization studies 
4.3.1 Stability and solubility of fibers 
 
The fiber-forming ability of polyelectrolytes is dependent on the stability of 
the viscous barrier between the two solutions. As seen from the table, the 
polyelectrolytes form fibers only within a specific range of concentrations. This 
suggests that the ability to draw continuous fibers requires a balance between 
stability of interface and the precipitation of complex in solution. This 
observation tallies with previous studies done with other polyelectrolytes. 
Lower concentration ranges are not sufficient to provide the solution with 
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enough viscosity, whereas higher concentrations cause rapid precipitation of 
polyionic complex in the solution, thus preventing fiber drawing. In the case of 
all peptides, a general concentration range of 6 – 8 µg/µL was found to be 
optimum. A slightly higher concentration (9 µg/µL) was required while using 
Tat and functional Tat peptides. This can be attributed to the fact that these 
peptides do not have hydrophobic regions present in the other amphipathic 
sequences. The presence of hydrophobic residues may play an important role 
in the interfacial self-assembly by providing the required viscosity to the 
solution. There may also be some peptide-peptide interactions via the 
hydrophobic patches that can give further stability to the fiber. 
At similar concentrations, interfacial area and the rate of drawing the fiber, 
there was a significant variation in fiber structure between different peptides. 
This difference was most easily seen in the diameter of fibers. The thinnest 
and weakest fibers were drawn from the Tat peptides, with the mean diameter 
of 5 µm. This can be attributed to the uneven distribution of positive charge 
along the peptide length. The absence of hydrophobic groups is also a major 
factor in fiber stability as it renders the solution more viscous and also 
promotes peptide-peptide interactions. 
Within the amphipathic peptides themselves, alanine containing peptides 
formed weaker fibers with mean diameters of 10 µm and 5 µm for AR20 and 
AR10 respectively as compared to the leucine peptides. This again supports 
the hypothesis that the hydrophobic nature of peptides also contributes to the 
fiber stability, since leucine (hydrophobicity index 97 at pH 7) is more 
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hydrophobic than arginine (hydrophobicity index 41 at pH 7). The strongest 
and longest fibers were formed by LR16 peptide with mean diameter of 15 µm 
followed by LR10 with mean diameter of 20 µm. However, the LR16 fibers 
were difficult to dissolve in aqueous solutions under different salt 
concentrations even after a 7-day period. LR10 peptide, on the other hand, 
formed strong and well-defined fibers which were stable in aqueous solutions 
up to 7 days, but dissolved slowly in serum containing cell-culture medium 
within 10 hours. We believe that the rapid dissolution of LR10 fibers is 
probably due to a combination of DNA degradation by serum and disruption 
of charge due to salt content. LR16 fibers probably resist this change due to 
almost complete charge neutralization and precipitation between the peptide 
and DNA. However, further characterization studies will be needed to offer a 
conclusive evidence for the remarkably different solubility of the fibers.  
4.3.2 Imaging and morphological studies 
 
LR10 peptide was used for all characterization studies. Transmission light 
microscopy of the fibers showed the characteristic features of interfacial 
polyelectrolyte fibers, with both beaded and non-beaded regions. At higher 
magnifications, the onion-like venation pattern in the beaded regions formed 
due to coalescence of nuclear fibers was also visible.  
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4.3.3 Confocal imaging 
 
Fluorescence labeling of LR10 peptide and DNA showed that the 
polyelectrolytes were uniformly incorporated in the fiber. The presence of 
nuclear fibers was seen clearly and the distribution of Hoechst-labeled DNA 
was uniform in these finer fibers. The confocal microscopy of FITC-labeled 
LR10 and PI-labeled DNA also revealed the presence of the two 
polyelectrolytes in the fiber. Since confocal microscopy is a technique that 
employs sequential scanning of layers, it is not possible to distinguish the 
exact interactions and structural assembly of peptide-DNA complex inside the 
fiber. However, the presence of large yellow regions formed due to 
overlapping of green and red dyes suggest extensive complexation. 
4.3.4 Surface topography 
 
We used FESEM to analyze the surface morphology of the fibers. The 
surface of a DNA–peptide fiber is uniform and smooth with faint parallel 
ridges along the fiber axis. These ridges form during the fiber drawing 
movement along the axis. Previous studies done on fibers made from 
chitosan–alginate also show similar topography.  
On comparing this fiber with a baculovirus encapsulated fiber, we found 
significant topographical difference. The fiber including virus particles showed 
well-defined, deep and regular ridges along the axis throughout the length of 
the fiber. These widely spaced ridges are deeper and more prominent 
compared to the smoother surface of fiber without virus. We surmise that 
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these ridges are unlikely to result solely due to fiber drawing, and are 
probably due to the incorporation of virus particles between the thinner 
nuclear fibers inside the primary fiber.  
4.3.5  Surface charge analysis 
 
The zeta potential on the surface of the fibers was measured using an 
electrokinetic analyzer. The surface charge of fiber without encapsulating 
baculovirus was found to be -14.8 mV. This negative value is to be expected 
since the DNA molecule has a long highly negative phosphate backbone. The 
N/P ratio – a ratio of the number of positively charged sites on the peptide 
and the negatively charged sites on plasmid DNA – can be calculated as 
1:500, thus showing significantly higher proportion of negative sites in the 
fiber.  It is important to note that the zeta potential of naked plasmid DNA is -
55 mV (±5 mV). Therefore, a value of -14.8 mV for the polyelectrolyte fiber 
still indicates significant charge neutralization due to interaction with the 
peptide. 
The surface charge of the fiber after inclusion of baculovirus showed a 
slightly more negative value of -16.8 mV. The zeta potential of free 
baculovirus at pH 6.5 has been measured around -10 mV, therefore a more 
negative surface charge of the virus-encapsulated fiber was also expected. 
Since this method measures only the surface charge, we have reason to 
believe that at least some fraction of the total number of virus particles 
encapsulated is exposed at the surface. This result, together with the FESEM 
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imaging, provides evidence that the virus interacts with the peptide as well as 
DNA during the charge neutralization process and is a part of the fiber 
structure.  
4.4 Transduction studies 
 
The main purpose of including baculovirus in the fiber structure was to test 
whether these fibers can mediate a sustained release of baculovirus. 
According to our hypothesis, the fiber would dissolve in the cell culture 
medium when the salt concentration disrupts the ionic complex in fiber. This 
will cause a slow release of virus which is still surrounded by peptide 
fragments, providing a slow transduction over a longer time scale.  
To test this hypothesis, we used U87 and U251 human glioma cell lines 
for transduction. The fibers encapsulating baculovirus were fabricated and 
laid on the bottom of 24-well plates. The number of fibers drawn for each well 
was determined by the volume of naked baculovirus used as the positive 
control. It should be mentioned here that the number of virus particles taken 
up in the fiber, and hence used for transduction, was always slightly less than 
the control. This is due to the fact that some amount of polyelectrolyte 
solution always remains as residual precipitated droplet and therefore it is not 
feasible to incorporate the exact volume of virus in the fibers as that in 
control.  
The cells were seeded on top of the fibers and incubated for 72 hours. 
The transduction efficiency was observed under fluorescence microscope at 
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different time points. We noticed that there was a significant increase in the 
number of transduced cells from 24 hours to 72 hours. Naked baculovirus 
transduced the cells completely in 16 hours, while there was almost no 
expression in the wells containing fibers at this time point. However, cells 
started showing expression at 48 hour time point, while the positive control 
showed no change. The intensity of green fluorescence as well as the 
number of green cells reached a maximum at 72 hours and was comparable 
to the positive control.  
These results give an indication that the virus is released slowly from 
fibers after it dissolves. The gradual increase in fluorescence intensity also 
suggests that the released virus is still surrounded by peptide fragments 
which need to be degraded extra- or intracellularly before expression can 
reach its optimum. The expression of reporter gene reaches significant levels 
only around 48 hours and continues to increase up to 72 hours after 
transduction as compared to 16 hours when using naked baculovirus.  
In another hypothesis, we proposed that these fibers could be used for 
gene delivery in a highly localized manner owing to the linear structure of the 
fibers. Since the virus is released from the fibers after dissolving, it should be 
possible to selectively transduce the cells on and around the fibers if the 
culture dish is incubated undisturbed.  
While using fibers made of non-functionalized amphiphilic peptides, we 
faced the problem of uneven distribution of cell density. This was because the 
fibers on the well surface occupied a large area, leaving only segregated 
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patches for the cells to attach. Since the fibers were made from simple 
amphipathic peptides and had an overall negative charge, they also did not 
interact with the cells.  
To overcome this problem, we designed a functionalized amphiphilic 
peptide LR10-RGD. The RGD sequence is a well-known cell attachment 
motif. We reasoned that if the cells could attach to the fibers, the transduction 
would be more site-specific.  
As seen from the results, cells were able to attach to the LR10-RGD 
fibers. To test if the fibers could transduce cells selectively in the region 
around the fibers, we used a confocal microscope to do a tile scan of a large 
area. The fibers were laid on a glass cover-slip in a single straight line and the 
position was marked. 48 hours after incubation, we observed transduced cells 
only in the fiber region. This result provides important evidence demonstrating 
that the fibers can aid cell attachment and provide region-specific delivery. It 
also suggests the possibility of further functionalization by incorporating other 
biological markers in the fiber structure. 
The property of the fibers to envelope and then slowly release the viral 
particles shows the potential use of the fibers as a protection against serum 
inactivation.  The serum complement inactivation is a hindrance to effective 
use of of baculovirus as gene delivery vector. Gene transfer efficiency by 
baculovirus is strongly hampered by triggered activation of the complement 
(C) system. In the past, some efforts have been made to block the 
complement cascade by using monoclonal antibodies, or by incorporating 
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decay-accelerating factor (DAF) – which also serves to block C system – into 
the baculovirus envelope. But these methods lead to a reduced viral titer 
which is a hurdle for in vivo and clinical studies [54, 55]. 
Another possible strategy to strengthen baculovirus vectors and enhance 
their in vivo gene delivery performance is virus particle surface modification. 
Previous studies have shown that through surface display method, which 
incorporates a functional element into the virus envelope, improved 
resistance of baculovirus to the serum complement attack can be achieved 
[56]. However, such biological modifications are tremendously time 
consuming and difficult. Therefore, more flexible and convenient methods for 
protection of viral vectors by altering the composition, modifying the structure, 
inserting functional components etc, need to be established. 
Encapsulation of viral particles for longer circulation time and safeguarding 
the vector is an extensively researched area. However, previous attempts to 
encapsulate viral particles have been focused on adenovirus and adeno-
associated virus. There have been several approaches to envelope viral 
vectors and thus prevent serum complement inactivation. Specifically, poly-
(lactide-co-glycolide) microspheres have been used to encapsulate 
adenoviruses, while cationic liposomes have been used for pre-treatment of 
retroviruses prior to gene delivery [58, 61]. In another reported instance, 
chitosan and bile salt microparticles have been used to encapsulate 
adenovirus for mucosal vaccination. Degradable starch microspheres have 
also been used for gene delivery to hepatocarcinoma via adenoviral vectors 
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[59]. All these treatments have shown a certain degree of protection and 
delayed infection to the target tissue.  
There are only a few reported researches on encapsulation of baculovirus, 
most often using polyethylene glycol (PEG) to regulate gene transduction 
efficiency [62]. The significant advantages of using baculovirus for gene 
delivery will be further improved if the issue of serum complement is 
addressed.  
Since these polyelectrolyte fibers dissolve slowly in cell culture medium, 
we reasoned that they will shield the baculovirus for a certain period prior to 
infection. We have already demonstrated that the virus does not show any 
significant loss in activity in the encapsulation process. Based on all the 
literature reviews and our results, these fibers have the potential of offering at 
least partial protection to the baculovirus under serum conditions. Therefore, 
we tested this hypothesis for a possible third application of these fibers. 
The preliminary results of transduction in the presence of rat serum show 
that the fibers can maintain the same release profile as in serum-free 
conditions, leading to a sustained release and delayed gene expression. It 
should be mentioned that the transduction protocol requires a prolonged 
incubation of the fibers with the cells in the presence of serum, which causes 
cytotoxicity at high serum concentrations. The longer incubation is essential 
because of the release profile of the fibers. We therefore tested the fibers 
under low serum concentration which has only partial inactivation effect on 
free virus. The fibers show a slightly increased level of gene expression as 
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compared to the free virus. However, further optimization of the current 
protocols could show a more significant improvement at higher serum 
concentrations. 
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5 Conclusion  
 
Our studies have focused on development of fibrous assemblies via 
interfacial non-covalent interactions of plasmid DNA, peptides and 
baculovirus. In the first part of the study, we optimized the conditions for fiber 
formation between DNA and a set of peptides. The chosen peptides were 
divided into three groups – Tat and Tat-derived peptides, amphipathic 
peptides and a functionalized amphipathic peptide. After optimization of fiber 
forming conditions, we characterized the outer morphology and inner 
structure of such fibers by using different imaging techniques. We also 
analyzed the surface charge of the fibers and monitored their solubility in 
different mediums. 
In the second part of the work, we incorporated baculovirus in the fiber 
structure. The virus particles are involved in the formation process from the 
very first step and the experimental evidence shows that they can be 
uniformly integrated in the fiber structure. This attempt showed that such 
assemblies can be formed using three large biological molecules. After 
optimizing the fiber formation with baculovirus, we did further characterization 
studies and our results show that the fibers including virus differ from those 
without virus in terms of surface topography and charge, but are similar in 
diameters and solubility characteristics. 
As a next step in the study, we tried to address the problem of serum 
complement challenge of baculovirus by using the polyelectrolyte fibers to 
protect and slowly release the virus in in vitro cell cultures. We demonstrated 
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that baculovirus can be integrated in the structure of these fibers with 
minimum loss of activity. This not only slows down virus release but also 
leads to a localized delivery pattern which can be exploited in applications like 
cell arrays and patterning. The preliminary results in the presence of serum 
show that the fibers perform in a similar manner as in serum-free medium and 
the transduction is comparable to that from free virus. More optimization of 
transduction protocols is likely to improve the protecting ability of the fibers 
against the serum. 
This study opens many possibilities for future work to develop the efficacy 
of this delivery system. One possible approach is to use different peptide 
sequences that can further regulate virus uptake. Histidine-rich peptides, due 
to a lesser positive charge than arginine-rich peptides, can be used to 
improve viral activity. Inclusion of more functional motifs in the peptide 
sequences is also possible. Additionally, more optimization of the existing 
data is needed in order to use these fibers in vivo.  
Since plasmid DNA is also a component of the fibers, new fabrication 
strategies and treatments can be optimized to use DNA-based gene delivery. 
This, coupled with viral gene delivery, can form a dual gene delivery system.  
Finally, there is also a possibility to include other viruses and other 
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